Literature DB >> 20701077

Comparison of the desmoplastic reaction and invading ability in invasive ductal carcinoma of the breast and prostatic adenocarcinoma based on the expression of heat shock protein 47 and fascin.

Nalan Nese1, Ali Rlza Kandiloglu, Gülin Simsek, Murat Lekili, Arzu Ozdamar, Arzu Catalkaya, Teoman Coskun.   

Abstract

OBJECTIVE: To investigate the diversity within invasive ductal carcinoma (IDC) and prostatic adenocarcinoma (PCa) by evaluating immunohistochemical expression of heat shock protein 47 (HSP47) and fascin, the molecules that are related to desmoplasia and invasion, and analyze its correlation with clinicopathologic parameters. STUDY
DESIGN: HSP47 and fascin immunoreactivity (IR) was evaluated in 49 mastectomies diagnosed as IDC and 57 radical prostatectomies diagnosed as PCa. IR was evaluated as: 0: < 5%, 1+: 5-25%, 2+: 25-50%, 3+: > 50%.
RESULTS: HSP47 and fascin were localized to cytoplasm, and HSP47 and fascin IR were higher in IDC and PCa than benign groups (p < 0.05). HSP47 IR in neoplastic cells was 42.1% and 28.6%, in stroma was 81.6% and 15.8% in IDC and PCa, respectively; fascin IR in neoplastic cells was 65.3% in IDC and 15.8% in PCa. Fascin expression correlated with estrogen receptor and progesterone receptor negativity, tumor size and stage in IDC and surgical margin status in PCa. HSP47 expression correlated bilaterality in PCa. HSP47 positively correlated with survival in IDC.
CONCLUSION: HSP47 and fascin expression may play role in the pathogenesis of IDC and PCa because their expression is significantly higher in IDC and PCa than their normal counterpart. Although there is no relationship with recurrence or metastatic status, fascin overexpression correlated with tumor size, which may prompt its use as a prognostic factor in IDC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20701077

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  5 in total

1.  Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer.

Authors:  Karen S Anderson; Sahar Sibani; Garrick Wallstrom; Ji Qiu; Eliseo A Mendoza; Jacob Raphael; Eugenie Hainsworth; Wagner R Montor; Jessica Wong; Jin G Park; Naa Lokko; Tanya Logvinenko; Niroshan Ramachandran; Andrew K Godwin; Jeffrey Marks; Paul Engstrom; Joshua Labaer
Journal:  J Proteome Res       Date:  2010-11-23       Impact factor: 4.466

2.  Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming.

Authors:  Yunjian Wu; Kimberley C Clark; Elizabeth V Nguyen; Birunthi Niranjan; Lisa G Horvath; Renea A Taylor; Roger J Daly
Journal:  Cell Oncol (Dordr)       Date:  2022-09-28       Impact factor: 7.051

3.  Analysis of Fascin-1 in Relation to Gleason Risk Classification and Nuclear ETS-Related Gene Status of Human Prostate Carcinomas: An Immunohistochemical Study of Clinically Annotated Tumours From the Wales Cancer Bank.

Authors:  Matthew T Jefferies; Christopher S Pope; Howard G Kynaston; Alan R Clarke; Richard M Martin; Josephine C Adams
Journal:  Biomark Cancer       Date:  2017-05-30

4.  Fascin-1 and its role as a serological marker in prostate cancer: a prospective case-control study.

Authors:  Octavian Sabin Tătaru; Orsolya Martha; Felice Crocetto; Biagio Barone; Septimiu Voidazan; Angela Borda; Anca Sin; Adina Hutanu; Andrada Loghin; Ileana Sin; Daniel Porav-Hodade; Calin Bogdan Chibelean; Liliana Vartolomei; Giuseppe Lucarelli; Matteo Ferro; Virgil Gheorghe Osan; Carlo Buonerba; Mihai Dorin Vartolomei
Journal:  Future Sci OA       Date:  2021-06-30

Review 5.  Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: a systematic review and meta-analysis.

Authors:  Vanessa Y Tan; Sarah J Lewis; Josephine C Adams; Richard M Martin
Journal:  BMC Med       Date:  2013-02-26       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.